US2013282004A1PendingUtilityA1
Circumferential ablation device assembly
Est. expiryMay 9, 2017(expired)· nominal 20-yr term from priority
Inventors:Michael D. Lesh
A61B 2018/00994A61B 2018/00375A61B 2018/00285A61B 2017/22067A61B 2017/22054A61B 18/00A61B 2017/22038A61B 2017/00243A61B 2018/00815A61B 18/1815A61B 2018/00369A61B 2218/002A61B 2018/00821A61B 2018/00839A61B 2018/00898A61B 2018/0016A61N 7/02A61B 18/1492A61B 2018/00273A61B 2018/00291A61B 2018/00011A61B 2018/00797A61B 2018/00214
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A circumferential ablation device assembly which is adapted to forming a circumferential conduction block in a pulmonary vein. The assembly includes a circumferential ablation element which is adapted to ablate a circumferential region of tissue along a pulmonary vein wall which circumscribes the pulmonary vein lumen, thereby transecting the electrical conductivity of the pulmonary vein against conduction along its longitudinal axis and into the left atrium.
Claims
exact text as granted — not AI-modified1 - 62 . (canceled)
63 . A method for treating atrial arrhythmia, comprising:
delivering an ablation element to atrial tissue corresponding to a target ablation region of the atrium; operating the ablation element to generate a lesion at one or more circumferential locations at the target ablation region; and monitoring an electrical conduction signal associated with the atrial tissue to verify presence of a conduction block at the ablation region.
64 . A method as recited in claim 63 , further comprising:
delivering a test stimulus at or near the ablation region; and wherein monitoring an electrical conduction signal comprises monitoring the test stimulus.
65 . A method as recited in claim 63 , wherein the lesion comprises a series of lesions aligned along a circumferential path.
66 . A method as recited in claim 65 , wherein the series of lesions substantially circumscribe the atrial wall of at the ablation region.
67 . A method as recited in claim 64 , wherein the ablation region is at or near an arrythmogenic origin associated with the atrium.
68 . A method as recited in claim 67 , wherein the ablation region is a location along a pulmonary vein wall between the arrythmogenic origin and the atrium.
69 . A method as recited in claim 68 , wherein the test stimulus is delivered above the ablation region along the pulmonary vein wall.
70 . A method as recited in claim 69 , wherein the electrical conduction signal is monitored at a location along a pulmonary vein wall between the arrythmogenic origin and the atrium.
71 . A method as recited in claim 63 , wherein monitoring an electrical conduction signal is performed via a plurality of electrodes.
72 . A method as recited in claim 71 , wherein the plurality of electrodes are substantially aligned along a circumferential path.
73 . A method as recited in claim 72 , wherein the plurality of electrodes are disposed along a looped support member.
74 . A method for treating atrial arrhythmia, comprising:
monitoring an electrical conduction signal associated with an atrial tissue to verify presence of an arrythmogenic signal at a target treatment region within the atrial tissue; delivering an ablation element to atrial tissue corresponding to the target treatment region; operating the ablation element to generate a lesion at one or more circumferential locations at the target treatment region.
75 . A method as recited in claim 74 , further comprising:
delivering a test stimulus at or near the treatment region; and monitoring an electrical conduction signal associated with the test stimulus.
76 . A method as recited in claim 74 , wherein the lesion comprises a series of lesions aligned along a circumferential path.
77 . A method as recited in claim 76 , wherein the series of lesions substantially circumscribe the atrial wall of at the treatment region.
78 . A method as recited in claim 75 , wherein the treatment region is at or near an arrythmogenic origin associated with the atrium.
79 . A method as recited in claim 78 , wherein the treatment region is a location along a pulmonary vein wall between the arrythmogenic origin and the atrium.
80 . A method as recited in claim 79 , wherein the test stimulus is delivered above the treatment region along the pulmonary vein wall.
81 . A method as recited in claim 79 , wherein the electrical conduction signal is monitored at a location along a pulmonary vein wall between the arrythmogenic origin and the atrium.
82 . A method as recited in claim 74 , wherein monitoring the electrical conduction signal is performed via a plurality of electrodes.
83 . A method as recited in claim 82 , wherein the plurality of electrodes are substantially aligned along a circumferential path.
84 . A method as recited in claim 83 , wherein the plurality of electrodes are disposed along a looped support member.
85 . A system for treating atrial arrhythmia, comprising:
an ablation element configured to generate a lesion at one or more circumferential locations at a target ablation region of atrial tissue; a delivery assembly configured for delivering an ablation element to the target ablation region; a processor coupled to one or more electrodes configured to be coupled to the atrial tissue; and programming executable on the processor to monitor an electrical conduction signal associated with the atrial tissue to verify presence of a conduction block at the ablation region.
86 . A method as recited in claim 85 , wherein the programming performs steps comprising:
delivering a test stimulus at or near the ablation region; and monitoring an electrical conduction signal associated with the test stimulus.
87 . A method as recited in claim 86 , wherein the ablation region is at or near an arrythmogenic origin associated with the atrium.
88 . A method as recited in claim 87 , wherein the ablation region is a location along a pulmonary vein wall between the arrythmogenic origin and the atrium.
89 . A method as recited in claim 88 , wherein the test stimulus is delivered above the treatment region along the pulmonary vein wall.
90 . A method as recited in claim 88 , wherein the electrical conduction signal is monitored at a location along a pulmonary vein wall between the arrythmogenic origin and the atrium.
91 . A method as recited in claim 86 , wherein monitoring the electrical conduction signal is performed via a plurality of electrodes.
92 . A method as recited in claim 91 , wherein the plurality of electrodes are substantially aligned along a circumferential path.
93 . A method as recited in claim 92 , wherein the plurality of electrodes are disposed along a looped support member.Join the waitlist — get patent alerts
Track US2013282004A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.